Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies

Clinical Laboratory

Volumn 59, Issue 11-12, 2013, Pages 1277-1287

  Caudie, Christiane ^a   Quittard Pinon, Arnaud ^a   Bouhour, Françoise ^b   Vial, Christophe ^b   Garnier, Lorna ^a   Fabien, Nicole ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Antibody profiles; ELISA; Gangliosides; Immunodot; Immunoline; Peripheral neuropathies

Indexed keywords

CARBOHYDRATE; GANGLIOSIDE ANTIBODY; GLYCOLIPID;

ARTICLE; ATAXIA; CANOMAD SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; HYDROPHOBICITY; IMMUNE MEDIATED PERIPHERAL NEUROPATHY; IMMUNOASSAY; IMMUNODOT ASSAY; LINE IMMUNO ASSAY; NEUROPATHY; NON AUTOIMMUNE NEUROPATHY; OPHTHALMOPLEGIA; PERIPHERAL NEUROPATHY; SENSORY NEUROPATHY;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; REAGENT KITS, DIAGNOSTIC;

EID: 84891597632     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.121116     Document Type: Article

References (24)

1. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-625. (Pubitemid 35423511)
2. Willison HJ, O'Leary CP, Veitch J, et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 2001;124:1968-77. (Pubitemid 32945898)
3. Ilyas AA, Quarles RH, Dalakas MC, et al. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol 1985;18:655-9. (Pubitemid 16085159)
4. Obi T, Kusunoki M, Takatsu, et al. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol Scand 1992;86:215-8.
5. Alaedani A, Latov N. Detection of anti-GM1 ganglioside antibodies in patients with neuropathy by a novel latex agglutination assay. J Immunoassay 2000;21:377-86.
6. Latov N, Alaedani A Detection of anti-glycolipid antibodies by latex agglutination assay.US0049692A1;2003.
7. Escande-Beillard N, David MJ, Portoukalian J, Pouget J, Azulay JP et al. A sensitive flow cytometry method for anti-GM1 antibody detection. J Neurol 2002;125:163-9. (Pubitemid 34327466)
8. Chabraoui F, Derrington EA, Mallié-Didier F, et al. Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membrane. J Immunol Methods 1993;165:225-30.
9. Caudie C, Vial C, Bancel J, et al. Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies. Ann Biol Clin 1999;57:579-88. French. (Pubitemid 29457400)
10. Caudie C. Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy. Clin Rev Allerg Immunol 2000;19:7-18.
11. Caudie C, Vial C, Bancel J, et al. Anti-ganglioside antibody profiles in Guillain-Barre syndrome. Ann Biol Clin Paris 2002;60:589-97. French.
12. Caudie C, Quittard Pinon A, Taravel D, et al. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients. J Neurol 2011;258:6042-9.
13. Caudie C, Vial C, Petiot P, et al. Serum antibody profiles against gangliosides and sulfatide in peripheral neuropathies: evaluation of a new immunoassay. Ann Biol Clin Paris 2010; 68(6):675-80. French.
14. Conrad K, Schneider H, Ziemssen T, et al. A new line immunoassay for the multiparametric detection of anti-ganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Ann NY Acad Sci 2007;1109:256-64. (Pubitemid 47511368)
15. Ravindranath MH, Morton DL, Graves MC. Factors affecting the fine specificity and sensitivity of serum anti-ganglioside antibodies in ELISA. J Immunol Methods 1994;169:257-72.
16. Willison HJ, Veitch J, Swan AV, et al. Inter-laboratory validation of an ELISA for determination of serum anti-ganglioside antibodies. Euro J Neurol 1999;6(1):71-7. (Pubitemid 29092362)
17. Vincent A. Measuring and evaluating the significance of autoantibodies in neurological disorders. Clin Applied Immunol Rev 2002;3:127-51. (Pubitemid 36024501)
18. Nobile-Orazio E, Carpo M, Legname G, et al. Anti-GM1 IgM antibodies in motor neuron disease and neuropathy. Neurology 1990;40:1747-50. (Pubitemid 20383144)
19. Willison HJ, Goodyear C, Brennan K, et al. Detection of interacttions between lipid complexes and lipid binding agents. WO 001131;2010.
20. Willison HJ. The immunology of Guillain Barré syndromes. J Peripher Nerv Syst 2005;10:94-112.
21. Roggenbuck D, Egerer K, von Landenberg P, et al. Antiphospholipid antibody profiling time for a new technical approach? Autoimmun Rev 2012;11:821-6.
22. Egerer K, Roggenbuck D, Buttner T, et al. Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay. Arthritis Res Ther 2011;13(4):R118.
23. Conrad K, Schößler W, Falk H, et al. Autoantibodies in organ specific autoimmune diseases. A diagnostic reference, editors: Berlin Pabst Science Publishers. 2011:65-9.
24. Willison HJ; Veitch J, Swan AV, et al. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Euro J Neurol 1999;6(1):71-7. (Pubitemid 29092362)